알피바이오 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 박재경, was filed 23 Nov 2023.
알피바이오: what insiders have been doing
알피바이오, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). The last twelve months, up to 2 November 2026, brought 1 filing signed by 1 insider.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
No insider has bought 알피바이오 shares on the open market in the past twelve months.
For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 1 filing here. Looking back to 2022, when coverage begins, insiders filed 13 purchases and 2 sales.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Since the insiders bought
- -37.0%Entry ₩8,790 · Close at T+365 ₩5,540
- -9.0%Entry ₩7,350 · Close at T+365 ₩6,690
- -40.1%Entry ₩14,100 · Close at T+365 ₩8,450
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- ●Executives0DART
- 5,176 shares@ ₩11,756.08100.0% of flowShareKRXDART:20231123000114Canonical exit: 21 Feb 2024 (T+90)
- 3,846 shares@ ₩13,000.00100.0% of flowShareKRXDART:20231020000041Canonical exit: 14 Jan 2024 (T+90)
- 395,351 sharesKRXDART:20230216001228
- 232,602 sharesKRXDART:20230113000511
- 2,282 shares@ ₩8,758.00100.0% of flowShareKRXDART:20221219000094Canonical exit: 12 Mar 2023 (T+90)
- 3,424 shares@ ₩8,758.00100.0% of flowShareKRXDART:20221219000092Canonical exit: 12 Mar 2023 (T+90)
- 5,708 shares@ ₩8,758.00100.0% of flowShareKRXDART:20221219000091Canonical exit: 12 Mar 2023 (T+90)
- 5,709 shares@ ₩8,758.00100.0% of flowShareKRXDART:20221219000089Canonical exit: 12 Mar 2023 (T+90)
- 4,950,213 sharesKRXDART:20221007000649Canonical exit: 9 Jan 2023 (T+90)
- 4,183,480 sharesShareKRXDART:20221007000515Canonical exit: 28 Dec 2022 (T+90)
- 2,711 sharesShareKRXDART:20221007000569Canonical exit: 28 Dec 2022 (T+90)
- 1,900 sharesShareKRXDART:20221007000583Canonical exit: 28 Dec 2022 (T+90)
- 1,722 sharesShareKRXDART:20221007000595Canonical exit: 28 Dec 2022 (T+90)
- 6,128 sharesShareKRXDART:20221007000554Canonical exit: 28 Dec 2022 (T+90)
- 872,990 sharesKRXDART:20221006000523Canonical exit: 4 Jan 2023 (T+90)
16 of 16 declarations
About 알피바이오
알피바이오 is a company in the health and pharmaceutical sector listed on the XKRX market. It focuses on developing innovative solutions in the biopharmaceutical field.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
